PINC Research is bullish on Glenmark Pharma and has recommended accumulate rating on the stock with a target of Rs 343 in its January 30, 2012 research report.

Buy Glenmark Pharma; target of Rs 360: KRChoksey

KRChoksey is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target of Rs 360 in its December 13, 2011 research report.

Accumulate Glenmark Pharma; target of Rs 345: PINC Research

PINC Research is bullish on Glenmark Pharma and has recommended accumulate rating on the stock with a target of Rs 345 in its December 13, 2011 research report.

Hold Glenmark Pharmaceuticals; target Rs 358: Nirmal Bang

Nirmal Bang has recommended hold rating on Glenmark Pharmaceuticals with a target price of Rs 358, in its November 18, 2011 research report.

Buy Glenmark Pharmaceuticals; target Rs 360: PINC Research

PINC Research is bullish on Glenmark Pharmaceuticals and has recommended buy rating on the stock with a target price of Rs 360 in its November 10, 2011 research report.

ACC, Bajaj Auto, Bharti Airtel top picks: Emkay

Emkay Global Financial Services has come out with its report on ACC, Bajaj Auto, Berger Paints, Bharti Airtel, Coromandel International.

Buy Glenmark Pharma; target of Rs 380: IIFL

IIFL is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target of Rs 380 in its September 29, 2011 research report.

Accumulate Glenmark Pharma; target Rs 368: Sushil Finance

Sushil Finance is bullish on Glenmark Pharmaceuticals and has recommended accumulate rating on the stock with a target of Rs 368 in its September 13, 2011 research report.

Sharekhan buys Glenmark Pharma, CESC; sells Lupin

Sharekhan has come out with its report on various stocks.

Buy Glenmark Pharmaceuticals; target of Rs 412: KRChoksey

KRChoksey is bullish on Glenmark Pharmaceuticals and has recommended buy rating on the stock with a target of Rs 412 in its August 08, 2011 research report.

Hold Glenmark Pharma; target of Rs 386: Nirmal Bang

Nirmal Bang has recommended hold rating on Glenmark Pharma with a target of Rs 386, in its July 29, 2011 research report.

Check out: Which stocks is Sharekhan betting on

Sharekhan has come with its report on various stocks.

Buy Glenmark Pharma; target of Rs 401: Emkay

Emkay Global Financial Services is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target price of Rs 401 in its July 26, 2011 research report.

Buy Glenmark Pharma; target of Rs 412: KRChoksey

KRChoksey is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target of Rs 412 in its July 27, 2011 research report.

Buy Glenmark Pharma; target of Rs 359: PINC Research

PINC Research is bullish on Glenmark Pharmaceuticals and has recommended buy rating on the stock with a target of Rs 359 in its July 26, 2011 research report.

Motilal Oswal neutral on Glenmark Pharma

Motilal Oswal has maintained neutral rating on Glenmark Pharma with a target of Rs 310, in its July 26, 2011 research report.

JPMorgan's cues on RIL, Glenmark; BoAML on PFC, Cummins Ind

JPMorgan is overweight on Reliance with a target of Rs 1200. Shale gas, petchem and India-centric service sector investments provide growth visibility and value options. They feel regulatory concerns are overdone.

Hold Glenmark Pharma; target of Rs 336: Nirmal Bang

Nirmal Bang has recommended hold rating on Glenmark Pharma with a target of Rs 336, in its May 11, 2011 research report.

Buy Glenmark Pharma; target of Rs 379: KRChoksey

KRChoksey is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target of Rs 379 in its March 29, 2011 research report.

Buy Glenmark Pharma; target of Rs 384: KRChoksey

KRChoksey is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target of Rs 384 in its February 01, 2011 research report.

Buy Glenmark Pharma; target of Rs 332: PINC Research

PINC Research is bullish on Glenmark Pharma and has recommended buy rating on the stock with a target of Rs 332 in its February 2, 2011 research report.

Buy Glenmark Pharma; target of Rs 400: Firstcall Research

Firstcall Research is bullish on Glenmark Pharmaceuticals and has recommended buy rating on the stock with a target of Rs 400 in its January 7, 2011 research report.